Introduction: Who Should Undergo Diagnostics

If you notice unusual symptoms, especially vaginal bleeding after menopause or between periods, it’s important to see your doctor without delay. Stage IV endometrial cancer is diagnosed when the disease has spread to areas beyond the uterus, making early detection through proper testing crucial for planning treatment^[2].

Women experiencing symptoms such as abnormal vaginal bleeding, pelvic pain or cramping, unexplained weight loss, or a feeling of fullness or a lump in the pelvic area should seek medical evaluation. These warning signs might indicate that cancer has progressed to an advanced stage^[2]. While these symptoms can be caused by many other conditions, only proper diagnostic testing can determine whether endometrial cancer is present and how far it has spread.

Stage IV endometrial cancer is broken into two subcategories. In stage 4A, cancer has spread into the bladder, bowel, or both organs. In stage 4B, cancer has traveled further beyond the pelvis to organs like the lungs or liver, or to distant lymph nodes^[2][5]. Understanding which subcategory applies to your situation requires thorough diagnostic work.

Your doctor will recommend specific tests based on your symptoms, medical history, and initial examination findings. The goal of diagnostics is not only to confirm the presence of cancer but also to determine how far it has spread, which directly influences treatment decisions. Only between 10 and 30 percent of endometrial cancer cases are diagnosed at stage 4, as most are caught earlier when symptoms first appear^[2].

Classic Diagnostic Methods

Diagnosing stage IV endometrial cancer involves several types of tests and examinations that help doctors see the full picture of where cancer is located and how it behaves. These methods range from simple physical exams to sophisticated imaging and laboratory procedures.

Pelvic Examination

The first step in diagnosing endometrial cancer is usually a pelvic exam. During this examination, your healthcare provider carefully checks your reproductive organs. The doctor inserts two gloved fingers into the vagina while pressing on your abdomen with the other hand to feel the uterus, ovaries, and surrounding structures. A device called a speculum is also inserted into the vagina to open the canal so the doctor can visually inspect for any abnormalities^[13][24].

While a pelvic exam can detect abnormalities, it cannot definitively diagnose cancer or determine its stage. However, in stage 4 cases, the doctor might feel a mass or lump in the pelvic area, which can be an early clue that cancer has spread^[2].

Imaging Tests

Imaging procedures create detailed pictures of the inside of your body and are essential for seeing exactly where cancer is located and how large it has grown. Several types of imaging may be used when stage IV endometrial cancer is suspected.

Transvaginal ultrasound is often one of the first imaging tests performed. During this procedure, a wand-like device called a transducer is gently inserted into your vagina. The transducer sends out sound waves that create images of your pelvic organs on a screen. This test is painless and helps doctors see the thickness of the endometrial lining and any abnormal masses^[13][24].

CT scans (computed tomography scans) use X-rays taken from different angles and combine them with computer processing to create detailed cross-sectional images of your body. CT scans are particularly useful for seeing whether cancer has spread to lymph nodes or other organs in the abdomen and pelvis^[15].

MRI scans (magnetic resonance imaging) use powerful magnets and radio waves instead of radiation to create very detailed images of soft tissues. MRI can show whether cancer has invaded the muscle wall of the uterus or spread to nearby structures. These scans are especially helpful in planning surgical treatment^[15].

PET scans (positron emission tomography) involve injecting a small amount of radioactive sugar into your bloodstream. Cancer cells absorb more sugar than normal cells, causing them to “light up” on the scan images. PET scans are particularly valuable for detecting cancer that has spread to distant organs or lymph nodes far from the uterus^[15].

Chest X-rays or CT scans of the chest may be ordered specifically to check whether endometrial cancer has spread to the lungs, which can occur in stage 4B disease^[2][5].

Tissue Sampling and Biopsy

To confirm a diagnosis of endometrial cancer, doctors need to examine actual tissue samples under a microscope. A pathologist — a doctor who specializes in studying tissues and cells — will look at these samples to determine if cancer is present and what type it is^[15].

An endometrial biopsy is a common way to obtain tissue samples. During this office procedure, your doctor inserts a thin tube through the cervix into the uterus and removes a small sample of the endometrial lining. The sample is then sent to a laboratory for analysis. This procedure can be uncomfortable but usually takes only a few minutes.

Hysteroscopy is another method that allows direct visualization of the inside of the uterus. A thin, lighted instrument called a hysteroscope is inserted through the vagina and cervix into the uterus. This lets the doctor see any abnormal areas and take tissue samples from specific locations^[13][24].

Surgical Staging

In many cases, the complete stage of endometrial cancer cannot be determined until surgery is performed. During surgical procedures, doctors can directly examine the uterus, surrounding tissues, and lymph nodes. They remove samples or entire organs for examination by a pathologist. This process, called surgical staging, provides the most accurate information about how far cancer has spread^[15].

A lymphadenectomy or lymph node dissection may be performed as part of surgical staging. This involves removing lymph nodes from the pelvis and sometimes from around the major blood vessel called the aorta. The pathologist examines these nodes to see if cancer cells are present, which helps confirm whether the disease has spread beyond the uterus^[15].

Laboratory Tests

Blood tests do not directly diagnose endometrial cancer, but they provide important information about your overall health and how your body is functioning. These tests help doctors understand whether organs like the liver or kidneys are affected by cancer spread and whether you are healthy enough for certain treatments.

Additionally, doctors may order biomarker testing on cancer tissue samples. Biomarkers are specific genes, proteins, or other characteristics of cancer cells. Understanding these markers helps doctors predict how aggressive the cancer might be and which treatments are most likely to work^[15].

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or combinations of treatments for cancer. If you have stage IV endometrial cancer, your doctor might recommend considering a clinical trial. To participate in these trials, you must meet specific criteria, and diagnostic tests play a crucial role in determining whether you qualify.

Standard Eligibility Requirements

Clinical trials have strict requirements called eligibility criteria that determine who can participate. These criteria are designed to ensure that the study tests treatments on the right group of patients and that participants are safe during the trial. Diagnostic tests help confirm that you meet these requirements.

Most clinical trials for stage IV endometrial cancer require confirmation of the cancer stage through imaging tests and sometimes surgical findings. Doctors need documented proof that cancer has spread to specific areas of the body. This usually means having CT scans, MRI scans, or PET scans performed within a certain timeframe before joining the trial^[3][9].

Pathology confirmation is almost always required. This means a tissue biopsy must have been examined by a pathologist who confirmed the diagnosis of endometrial cancer. The pathology report provides details about the type of cancer cells and other characteristics that might affect treatment decisions.

Performance Status Assessment

Clinical trials typically require patients to have a certain level of physical fitness and ability to care for themselves. This is measured using something called a performance status score. Your doctor will assess how well you can perform daily activities and how much cancer symptoms are affecting your life. This assessment helps determine whether you are strong enough to tolerate the experimental treatment being studied.

Organ Function Testing

Before enrolling in a clinical trial, you will likely need blood tests to check how well your major organs are functioning. These tests typically include measuring liver function, kidney function, and blood cell counts. Clinical trials need to ensure that participants’ organs are working well enough to process and tolerate new treatments safely.

Heart function may also be evaluated, especially if the clinical trial involves treatments that could affect the heart. An electrocardiogram (EKG) or echocardiogram might be required to check your heart’s electrical activity and pumping ability.

Biomarker and Molecular Testing

Many modern clinical trials focus on precision medicine, which means treatments are tailored to the specific genetic or molecular characteristics of your cancer. To qualify for these trials, you may need specialized testing of your tumor tissue to look for specific biomarkers, gene mutations, or protein expressions.

For example, some clinical trials might test treatments that work specifically for cancers with certain genetic changes or for tumors that express particular proteins on their surface. Identifying these characteristics requires advanced laboratory testing on biopsy samples^[15].

Immunotherapy trials often require testing to see whether your cancer cells express a protein called PD-L1 or have characteristics called microsatellite instability (MSI) or mismatch repair deficiency (dMMR). These features help predict whether certain immunotherapy treatments might be effective^[5].

Imaging for Measurable Disease

Most clinical trials require participants to have “measurable disease,” which means tumors that can be seen and measured on imaging scans. This is important because researchers need to track whether the treatment is causing tumors to shrink, stay the same size, or grow larger. Baseline imaging — scans performed before treatment starts — establishes a reference point for comparison with scans taken later during the trial.

The specific imaging requirements vary by trial but commonly include CT scans or MRI scans of the chest, abdomen, and pelvis. Some trials may also require PET scans. These images are carefully measured by radiologists to document the size and location of all visible tumors.

Repeat Testing During Trials

Once enrolled in a clinical trial, you will undergo regular diagnostic tests to monitor how the treatment is affecting your cancer and your overall health. This typically includes repeat imaging scans at scheduled intervals (often every 6 to 12 weeks) and regular blood tests to check organ function and blood cell counts.

These ongoing tests serve two purposes: they help your medical team watch for any concerning side effects or complications, and they provide data that researchers use to determine whether the experimental treatment is working. The frequency and types of monitoring tests are specified in the trial protocol.